Romark begins phase III trial of COVID-19 antiviral
August 11, 2020 -- Romark has initiated a phase III clinical trial of its investigational new drug candidate Nt-300 (nitazoxanide extended-release tablets) as a treatment for mild or moderate COVID-19.
Novocellbio's COVID-19 cell therapy shows promising results
August 10, 2020 -- Novocellbio has confirmed that its autologous natural killer cell treatment agent is effective in killing SARS-CoV-2.
CROs offer new COVID-19 services
August 6, 2020 -- Contract research organizations (CROs) Caprion-HistoGeneX and Viroclinics have formed a strategic partnership to develop therapeutics and prophylactic solutions targeting infectious diseases like COVID-19.
Kriya establishes internal gene therapy manufacturing capacity
August 5, 2020 -- Kriya Therapeutics has secured a 51,000-sq-ft facility in Research Triangle Park, NC, to establish internal operational manufacturing of its pipeline of adeno-associated virus-based gene therapies.
Twist Bioscience, Seismic Bio partner to discover bispecific antibodies
August 4, 2020 -- Twist Bioscience and Seismic Bio have formed a partnership to discover and optimize antibodies to high-value immuno-oncology targets.
Immunoprecise highlights combo neutralization of antibodies
July 31, 2020 -- Immunoprecise Antibodies has conducted additional characterization of a subset of fully human, therapeutic SARS-CoV-2 antibodies that are potent and exhibit enhanced neutralization upon combinatorial testing.
Enterome begins trial for microbiome-based immunotherapy
July 31, 2020 -- Clinical-stage biopharmaceutical company Enterome has begun its first clinical trial for E02401, a microbiome-based cancer immunotherapy candidate.
Direct Biologics begins phase II trial for COVID-19 ExoFlo therapy
July 30, 2020 -- Regenerative medical products manufacturer Direct Biologics has won approval from the U.S. Food and Drug Administration to study its ExoFlo therapy in a clinical trial with COVID-19 patients.
SAB Biotherapeutics begins seasonal flu immunotherapy clinical trial
July 30, 2020 -- SAB Biotherapeutics has begun a phase I clinical trial evaluating SAB-176 for the treatment of seasonal influenza.
Intravacc, Celonic to jointly develop COVID-19 vaccine
July 29, 2020 -- Vaccine development firm Intravacc and biopharmaceutical contract development and manufacturing organization Celonic are teaming up to develop a COVID-19 vaccine.
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
General Discussion
Topic Replies / Views Last Update
Childhood vaccines may help protect against COVID-19 mortality
by Ratcatcher
0 / 6 More than 3 days ago
by Ratcatcher
by Michael
0 / 49 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 13 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 15 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter